Vedenie beremennostey, nastupivshikh posle ekstrakorporal'nogo oplodotvoreniya u zhenshchin s privychnym nevynashivaniem, obuslovlennym immunologicheskimi narusheniyami
- Authors: Agadzhanova AA1, Tetruashvili NK1, Sidel'nikova VM1, Kuz'michev LN1, Sukhikh GT1
-
Affiliations:
- ГУ Научный центр акушерства, гинекологии и перинатологии, Москва
- Issue: Vol 8, No 5 (2006)
- Pages: 32-35
- Section: Articles
- URL: https://journals.rcsi.science/2079-5831/article/view/27790
- ID: 27790
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
A A Agadzhanova
ГУ Научный центр акушерства, гинекологии и перинатологии, Москва
N K Tetruashvili
ГУ Научный центр акушерства, гинекологии и перинатологии, Москва
V M Sidel'nikova
ГУ Научный центр акушерства, гинекологии и перинатологии, Москва
L N Kuz'michev
ГУ Научный центр акушерства, гинекологии и перинатологии, Москва
G T Sukhikh
ГУ Научный центр акушерства, гинекологии и перинатологии, Москва
References
- Ghazeeri G.S, Kutteh W.H. Immunological testing and treatment in reproduction: frequency assessment of practice patterns at assisted reproduction clinics in the USA and Australia. Hum Reprod 2001; 16 (10): 2130–5.
- Laird S.M, Tuckerman E.M, Li T.C. Cytokine expression in the endometrium of women with implantation failure and recurrent miscarriage. Reprod Biomed Online 2006; 13 (1): 13–23.
- Tomassetti C, Meuleman C, Pexsters A et al. Endometriosis, recurrent miscarriage and implantation failure: is there an immunological link? Reprod Biomed Online. 2006; 13 (1): 58–64.
- Christiansen O.B. Evidence - based investigations and treatments of recurrent pregnancy loss. Curr Opin Obstet Gynecol 2006; 18 (3): 304–12.
- Szekeres-Bartho J, Faust Z, Varga P et al. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production. Am J Reprod Immunol 1996; 35 (4): 348–51.
- Halbmayer W.M, Feichtinger W, Kindermann C et al. Recurrent miscarriage or failed in - vitro fertilization: antibodies against annexin V, cardiolipin, beta-2-glycoprotein-1 and APC-resistance. Hamostaseologie 2005; 25 (4): 391–3.
- Heilmann L. Antithrombotic therapy in high risk pregnancy. Hematol Oncology Clin North Am 2000; 13 (5): 1133–50.
- Matsubayashi H, Arai T, Izumi S. Anti - annexin V antibodies in patients with early pregnancy loss or implantation failures. Fertil Steril 2001; 76 (4): 694–9.
- Stern C, Chamley L. Antiphospholipid antibodies and coagulation defects in women with implantation failure after IVF and recurrent miscarriage. Reprod Biomed Online 2006; 13 (1): 29–37.
- Stern C, Chamley L, Hale L et al. Antibodies to beta2 glycoprotein I are associated with in vitro fertilization implantation failure as well as recurrent miscarriage: results of a prevalence study. Fertil Steril 1998; 70 (5): 938–44.
- Nardo L.G, Sallam H.N. Progesterone supplementation to prevent recurrent miscarriage and to reduce implantation failure in assisted reproduction cycles. Reprod Biomed Online 2006; 13 (1): 47–57.
Supplementary files
